Teva Pharmaceutical (TEVA)

Quick facts

Marketed products

• Austedo · Metabolic · revenue 1100
  Austedo works by binding to the synaptic vesicular amine transporter, reducing the release of dopamine and other neurotransmitters.
• Copaxone · Immunology · revenue 700
  Copaxone works by modulating the immune system's response to reduce inflammation in the central nervous system.
• Ajovy · Neuroscience · revenue 600
  Ajovy works by blocking the action of calcitonin gene-related peptide 1 (CGRP1), a molecule involved in pain transmission.
• Cutivate · Oncology · revenue 69.0
• Diamox · Immunology
• AKLIEF® · Dermatology
• Zebeta · Cardiovascular
• SHEUR · Other
• Tussionex Pennkinetic · Neuroscience
  Tussionex Pennkinetic works by binding to opioid receptors in the brain, which helps to reduce pain and congestion.
• Mycamine · Infectious Disease
• Synribo · Oncology
• Orap · Neuroscience
• Azilect · Metabolic
• Cinqair · Respiratory
  Cinqair works by blocking the action of interleukin-5, a protein that promotes the production of eosinophils, which contribute to inflammation in the airways.
• Istodax · Oncology
  Romidepsin inhibits HDACs, leading to increased acetylation of histones and non-histone proteins, causing cell cycle arrest and apoptosis in cancer cells.
• Zanosar · Oncology
• Surmontil · Neuroscience

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Teva Pharmaceutical portfolio CI brief
• Teva Pharmaceutical pipeline updates RSS